Equities
  • Price (EUR)44.60
  • Today's Change-0.55 / -1.22%
  • Shares traded10.00
  • 1 Year change+21.03%
  • Beta0.5413
Data delayed at least 15 minutes, as of Feb 06 2026 07:00 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Gimv NV is a Belgium-based investment company. The five segments of the Company are investment platforms: Consumer, Healthcare, Life sciences, Smart industries, Sustainable cities. The Consumer platform focuses on companies that respond to current and future consumer needs and preferences. In the Health and Care platform, the Company invests in biotechnology, medical technology, and service companies in the health & care sector. Through Smart Industries platform the Company invests in innovation and intelligent technologies. The Sustainable Cities platform focuses on construction & materials, energy and environment, transport, logistics and mobility, and industrial services. The Company invests as well, in third-party funds and infrastructure.

  • Revenue in EUR (TTM)400.80m
  • Net income in EUR201.06m
  • Incorporated1980
  • Employees94.00
  • Location
    Gimv NVKarel Oomsstraat 37ANTWERPEN 2018BelgiumBEL
  • Phone+32 32902100
  • Fax+32 32902105
  • Websitehttps://www.gimv.com/en
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
GIMB:BRU since
announced
Transaction
value
Novicare BVAnnounced28 Aug 202528 Aug 2025Announced0.23%--
Alpine Nederland BVDeal completed24 Jun 202524 Jun 2025Deal completed1.73%--
Ambulantis Bsw GmbHDeal completed05 May 202505 May 2025Deal completed8.51%--
The Spice Factory SADeal completed20 Feb 202520 Feb 2025Deal completed20.05%--
Data delayed at least 15 minutes, as of Feb 06 2026 16:35 GMT.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.